Robinson, Philip S. http://orcid.org/0000-0002-6237-7159
Coorens, Tim H. H. http://orcid.org/0000-0002-5826-3554
Palles, Claire
Mitchell, Emily
Abascal, Federico http://orcid.org/0000-0002-6201-1587
Olafsson, Sigurgeir
Lee, Bernard C. H.
Lawson, Andrew R. J.
Lee-Six, Henry http://orcid.org/0000-0003-4831-8088
Moore, Luiza http://orcid.org/0000-0001-5315-516X
Sanders, Mathijs A.
Hewinson, James
Martin, Lynn
Pinna, Claudia M. A. http://orcid.org/0000-0002-5618-7842
Galavotti, Sara
Rahbari, Raheleh http://orcid.org/0000-0002-1839-7785
Campbell, Peter J. http://orcid.org/0000-0002-3921-0510
Martincorena, IƱigo http://orcid.org/0000-0003-1122-4416
Tomlinson, Ian http://orcid.org/0000-0003-3037-1470
Stratton, Michael R. http://orcid.org/0000-0001-6035-153X
Funding for this research was provided by:
Wellcome Clinical PhD fellowship
Wellcome PhD Studentship
Jean Shank/Pathological Society Intermediate Fellowship
Cancer Research UK (C66259/A27114)
Article History
Received: 17 February 2021
Accepted: 28 July 2021
First Online: 30 September 2021
Competing interests
: P.J.C. is a founder, consultant and stockholder of Mu Genomics Ltd. The other authors declare no competing interests.